416 related articles for article (PubMed ID: 30817592)
1. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.
Takeuchi M; Kanda T; Kaburaki T; Tanaka R; Namba K; Kamoi K; Maruyama K; Shibuya E; Mizuki N
Medicine (Baltimore); 2019 Mar; 98(9):e14668. PubMed ID: 30817592
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan.
Fukuda Y; Yawata N; Hasegawa E; Yamana S; Shirane M; Ito T; Takeda A; Sonoda M; Eguchi K; Ishimura M; Ohga S; Sonoda KH
Ocul Immunol Inflamm; 2023 Dec; 31(10):2032-2038. PubMed ID: 37917805
[TBL] [Abstract][Full Text] [Related]
3. Use of systemic corticosteroids in patients newly registered at a claims database with a diagnosis of non-infectious uveitis: results from a real-world claims database analysis.
Umazume A; Ohguro N; Okada AA; Namba K; Sonoda KH; Tsuruga H; Morita K; Goto H
Jpn J Ophthalmol; 2022 Jul; 66(4):394-404. PubMed ID: 35670922
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.
Silvestri E; Bitossi A; Bettiol A; Emmi G; Urban ML; Mattioli I; Di Scala G; Bacherini D; Lopalco G; Venerito V; Iannone F; Vitale A; Tosi GM; Rizzo S; Fabiani C; Cantarini L; Virgili G; Vannozzi L; Prisco D
Inflammopharmacology; 2020 Jun; 28(3):711-718. PubMed ID: 32157555
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
6. Noninfectious immune-mediated uveitis and ocular inflammation.
Pan J; Kapur M; McCallum R
Curr Allergy Asthma Rep; 2014 Jan; 14(1):409. PubMed ID: 24338488
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database.
Umazume A; Ohguro N; Okada AA; Namba K; Sonoda KH; Tsuruga H; Morita K; Goto H
Jpn J Ophthalmol; 2021 Sep; 65(5):657-665. PubMed ID: 34181111
[TBL] [Abstract][Full Text] [Related]
8. Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia.
Al-Qarni A; Abouammoh MA; Almousa AN; Mousa A; Abu El-Asrar AM
Int Ophthalmol; 2019 Feb; 39(2):317-333. PubMed ID: 29318438
[TBL] [Abstract][Full Text] [Related]
9. Three cases of tubulointerstitial nephritis and uveitis syndrome with different clinical manifestations.
Nagashima T; Ishihara M; Shibuya E; Nakamura S; Mizuki N
Int Ophthalmol; 2017 Jun; 37(3):753-759. PubMed ID: 27511057
[TBL] [Abstract][Full Text] [Related]
10. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY).
Agarwal AK; Sudharshan S; Mahendradas P; Babu K; Shenoy P; Dogra M; Bansal R; Agarwal M; Biswas J; Balamurugan S; Agrawal R; Gupta V
Br J Ophthalmol; 2022 Jan; 106(1):97-101. PubMed ID: 33011688
[TBL] [Abstract][Full Text] [Related]
12. Clinical Patterns and Causes of Intraocular Inflammation in a Uveitis Patient Cohort from Egypt.
Amin RM; Goweida M; Bedda A; Kamel A; Radwan A
Ocul Immunol Inflamm; 2019; 27(6):859-867. PubMed ID: 27782772
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of uveitis in the Tunis area].
Chebil A; Baroudi B; Slim M; Chaker N; Lamloum M; Bouladi M; Houman H; El Matri L
J Fr Ophtalmol; 2013 Nov; 36(9):764-8. PubMed ID: 23932485
[TBL] [Abstract][Full Text] [Related]
15. Ocular manifestations and clinical outcomes in Tubulointerstitial Nephritis and Uveitis Syndrome (TINU).
Uludag Kirimli G; Hassan M; Onghanseng N; Or C; Yasar C; Park S; Akhavanrezayat A; Mobasserian A; Yavari N; Bazojoo V; Khojasteh H; Ghoraba H; Karaca I; Trong Tuong Than N; Zaidi M; Nguyen QD
Eye (Lond); 2024 Feb; 38(2):349-356. PubMed ID: 37626158
[TBL] [Abstract][Full Text] [Related]
16. Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis.
Namba K; Takase H; Usui Y; Nitta F; Maruyama K; Kusuhara S; Takeuchi M; Azumi A; Yanai R; Kaneko Y; Hasegawa E; Nakai K; Tsuruga H; Morita K; Kaburaki T
Jpn J Ophthalmol; 2022 Mar; 66(2):130-141. PubMed ID: 35044561
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Uveitis in a Tertiary Care Referral Institute in Saudi Arabia.
Al Dhibi HA; Al Shamsi HN; Al-Mahmood AM; Al Taweel HM; Al Shamrani MA; Arevalo JF; Gupta V; The Kkesh Uveitis Survey Study Group
Ocul Immunol Inflamm; 2017 Jun; 25(3):388-395. PubMed ID: 26910754
[TBL] [Abstract][Full Text] [Related]
18. Patterns and Etiologies of Uveitis at a Tertiary Referral Center in Taiwan.
Chen SC; Chuang CT; Chu MY; Sheu SJ
Ocul Immunol Inflamm; 2017; 25(sup1):S31-S38. PubMed ID: 27463023
[TBL] [Abstract][Full Text] [Related]
19. Changing patterns of intraocular inflammatory disease in Japan.
Wakabayashi T; Morimura Y; Miyamoto Y; Okada AA
Ocul Immunol Inflamm; 2003 Dec; 11(4):277-86. PubMed ID: 14704899
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
